Evidence map›Paper›PMID 11602620›Full record

ArticleThe Journal of clinical investigation2001

Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity.

A J Slavin, J M Soos, O Stuve, J C Patarroyo, H L Weiner, A Fontana, E K Bikoff, S S Zamvil

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 89 citations in OpenAlex.

  1. Review
  2. MOG CNS Autoimmunity and MOGAD.Neurology(R) neuroimmunology & neuroinflammation · 2024
    Review
  3. Article
  4. T cell deletional tolerance restricts AQP4 but not MOG CNS autoimmunity.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  5. Review
  6. Article
  7. Article
  8. Tregs restrain dendritic cell autophagy to ameliorate autoimmunity.The Journal of clinical investigation · 2017
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

A J SlavinCenter for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
J M Soos
O Stuve
J C Patarroyo
H L Weiner
A Fontana
E K Bikoff
S S Zamvil
University of California, San Francisco · USHarvard University · USBrigham and Women's Hospital · USUniversity Hospital of Zurich · CH

Funding

MHC CLASS II TRANSACTIVATOR (CIITA) IN CNS AUTOIMMUNITYK02NS002207 · NINDS · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI ZAMVIL, SCOTT S · 2001 to 2004
$514k
NINDS NIH HHS K02 NS002207NINDS NIH HHS K02 NS02207
6 · The paper itself

Abstract

The role of processing in antigen (Ag) presentation and T cell activation in experimental allergic encephalomyelitis (EAE) was evaluated in wild-type mice, mice that selectively express either Ii p31 or p41, and mice completely deficient in Ii or H-2M. We demonstrate that processing of myelin oligodendrocyte glycoprotein (MOG) is required for presentation of the dominant encephalitogenic MOG epitope, p35-55. Ii p31- and p41-expressing mice developed EAE with similar incidence to wild-type mice, although p41 mice had a more severe course. Ag-presenting cells (APCs) from Ii- or H-2M-deficient mice could present p35-55, but not MOG, demonstrating that these APCs could not process native MOG. Ii- and H-2M-deficient mice were not susceptible to EAE by immunization with p35-55 or MOG or by adoptive transfer of encephalitogenic T cells. However, CD4+ T cells from p35-55-immunized H-2M-deficient mice proliferated, secreted IFN-gamma, and transferred EAE to wild-type, but not H-2M-deficient, mice. Thus, EAE resistance in H-2M-deficient mice is not due to an inability of APCs to present p35-55, or an intrinsic defect in the encephalitogenic T cell repertoire, but reflects a defect in APC function. Our results indicate that processing is required for initial Ag presentation and CNS T cell activation and suggest that autopathogenic peptides of CNS autoantigen may not be readily available for presentation without processing.

Indexed as

Antigen PresentationAnimalsAntigens, Differentiation, B-LymphocyteAutoantigensBase SequenceDNA, ComplementaryEncephalomyelitis, Autoimmune, ExperimentalEndocytosisH-2 AntigensHistocompatibility Antigens Class IILymphocyte ActivationMiceMice, Inbred C57BLMice, Mutant StrainsMyelin-Associated GlycoproteinMyelin-Oligodendrocyte GlycoproteinAntigens, Differentiation, B-LymphocyteAutoantigensDNA, ComplementaryH-2 AntigensHistocompatibility Antigens Class IIinvariant chainMog protein, mouseMyelin-Associated GlycoproteinMyelin-Oligodendrocyte GlycoproteinMyelin ProteinsRNA, Messenger

Identifiers

PMID11602620
PMCPMC209531
OpenAlexW2088247694

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.